任职获批尚不满一年，国联人寿总经理赵雪军"闪辞"。 近日，国联人寿保险股份有限公司（下称国联人寿）披露的公告显示，国联人寿第四届董事会第二十三 次会议通过了《关于公司聘任临时负责人的议案》。根据有关规定，国联人寿决定聘任钮磊磊为临时负 责人，赵雪军因个人原因辞任国联人寿总经理职务。 2024年4月，国联人寿时任总经理夏寒辞职，曾任中融人寿副总经理的赵雪军任国联人寿临时负责人。 今年1月，国联人寿发布公告称，公司董事会同意聘任赵雪军为公司总经理。1月10日，国家金融监督管 理总局江苏监管局核准了赵雪军的总经理任职资格。 赵雪军出生于1975年10月，早年任职于国华人寿，曾任银行保险部总经理兼新渠道业务部总经理，上海 分公司总经理。2011年4月，他加盟中融人寿任总公司营销管理中心副总经理。2012年1月起担任中融人 寿江苏分公司总经理，2014年7月起任中融人寿总经理助理，2018年5月起任中融人寿副总经理。 在中融人寿任职副总经理期间，赵雪军曾分管银保业务。 值得注意的是，在赵雪军获批出任国联人寿总经理两个多月后，时任国联人寿董事长丁武斌到龄退休。 接替他的，是出生于1981年6月的无锡市国联发展（集团）有限 ...

Core Points - The stock price of Hangmin Co., Ltd. (600987) closed at 7.15 yuan on October 24, 2025, down 2.72% with a turnover rate of 1.53% and a trading volume of 156,100 shares, amounting to a total transaction value of 112 million yuan [1] Financial Performance - For the third quarter of 2025, the company's operating revenue was 2,694,512,070.14 yuan, a decrease of 12.52% compared to the same period last year [1] - The total profit for the period was 233,915,787.33 yuan, down 5.78% year-on-year [1] - The net profit attributable to shareholders was 168,217,307.11 yuan, a decline of 5.02% year-on-year, while the net profit after deducting non-recurring gains and losses was 164,540,211.39 yuan, down 0.66% [1] - The basic earnings per share were 0.165 yuan, a decrease of 1.79% compared to the previous year [1] - The weighted average return on net assets was 2.44%, a decrease of 0.20 percentage points [1] Capital Increase - The company has completed a capital increase of 45 million yuan for Hangmin Kear Gold Co., Ltd., raising its registered capital from 5 million yuan to 50 million yuan [1][2]

Core Viewpoint - The company and its wholly-owned subsidiaries plan to invest a total of 660 million yuan in its subsidiary, Hengxing Chemical, to enhance its market competitiveness and align with strategic development needs [1] Investment Details - The company will contribute 310 million yuan to Hengxing Chemical - Hengxing Metal will invest 200 million yuan - Hengxing Steel Cable will provide 150 million yuan - Post-investment, Hengxing Chemical's registered capital will increase from 671 million yuan to 963 million yuan [1] Strategic Implications - The capital increase is aimed at improving the product market competitiveness of Hengxing Chemical - This move is consistent with the company's strategic planning and operational development requirements [1]

格隆汇10月23日丨太平鸟(603877.SH)公布，为保障宁波高新区太平鸟全球时尚研发中心项目顺利实 施，优化项目实施主体风尚服饰的资产负债结构，增强风尚服饰的资金实力，公司于2025年10月23日召 开第五届董事会第七次会议审议通过了《关于使用部分募集资金及自有资金向全资子公司增资的议 案》，同意公司向风尚服饰增资10亿元，其中使用募集资金增资2亿元用于实施募集资金投资项目（以 下简称"募投项目"），使用自有资金增资8亿元用于日常运营。本次增资完成后，风尚服饰注册资本由 0.95亿元增加至10.95亿元，仍为公司的全资子公司。同时，公司董事会已授权管理层在增资额度范围内 签署相关合同文件，并根据风尚服饰的实际使用需要，分期分批缴付出资。 ...

Group 1 - The core point of the article is that Jiangxi Naipu Mining Machinery Co., Ltd. has approved a capital increase of 22 million yuan for its subsidiary, Shanghai Naipu International Trade Co., Ltd., to optimize its financial structure and enhance operational capabilities [1][5][8] Group 2 - The board meeting was held on October 23, 2025, with all seven directors present, and the meeting procedures complied with the Company Law and the company's articles of association [2][4] - The third quarter report for 2025 was approved, reflecting the company's operational status accurately and completely, with no false records or significant omissions [3][5] - The voting results for both the third quarter report and the capital increase proposal were unanimous, with 7 votes in favor and no opposition or abstentions [4][6]

Group 1 - The core point of the article is the significant increase in registered capital of Ant Future (Hainan) Information Technology Co., Ltd. from 10 million RMB to 3.5 billion RMB, representing a growth of 34,900% [1][2] - The company was established in March 2018 and is wholly owned by Ant Group's Hangzhou Ant Future Technology Co., Ltd. [1][2] - The business scope of the company includes information technology consulting services, software development and design, and financial technology outsourcing for financial institutions [1][2] Group 2 - The capital change was officially recorded on October 17, 2025, indicating a formal update in the company's registration details [2] - Prior to the change, the registered capital was 10 million RMB, and after the change, it is now 3.5 billion RMB [2] - The ownership structure remains unchanged, with Hangzhou Ant Future Technology Co., Ltd. maintaining a 100% stake in the company [2]

Core Viewpoint - COFCO Technology announced a capital increase for Jilin COFCO Biochemical Packaging Co., Ltd. to address financial pressures due to weak downstream market demand and reduced packaging material usage [1][3] Group 1: Capital Increase Details - The capital increase will not exceed 90 million yuan, utilizing COFCO Technology's own funds [2] - After the capital increase, the shareholding structure will change, with Changheng Co., Ltd. holding no less than 36.9603% and COFCO Technology holding no more than 63.0397% [2] Group 2: Financial Impact - The capital increase aims to effectively reduce the asset-liability ratio of Jilin COFCO Biochemical Packaging Co., Ltd., repay interest-bearing debts, enhance bank credit limits and financing capabilities, lower financing costs, and improve financial conditions [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688513 证券简称：苑东生物 公告编号：2025-073 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、已披露的增资暨关联交易概述 为加快公司创新转型战略的实施步伐，推动公司从仿制药向创新全面转型，公司分别于2025年9月23日 召开第四届董事会第八次会议、于2025年10月9日召开2025年第二次临时股东大会，审议通过了《关于 向参股公司增资暨关联交易的议案》，由公司全资子公司苑东生物投资管理（上海）有限公司（以下简 称"上海投资公司"）作为投资主体以货币资金的形式对上海超阳实施增资，增资价格为2.27元/注册资 本，增资总金额8,571.00万元（对应上海超阳注册资本3,771.00万元），资金来源均为自有资金。本次增 资完成后，上海超阳的注册资本将由原8,800.00万元增加至12,571.00万元，公司间接持有上海超阳的股 权比例将由30.68%增加至51.48%，上海超阳将变更为公司控股子公司，纳入公司合并报表范围。 具体内容详见公司于2025 ...

智通财经APP讯，龙图光罩(688721.SH)发布公告，公司全资子公司珠海龙图为公司上市募投项目建设 的主体，为了保障项目建设需求以及相关项目顺利开展，增强珠海龙图的资本实力，提高其运营能力， 完善公司的战略规划，公司拟以自有资金向珠海龙图增资3亿元人民币，本次增资后，珠海龙图注册资 本将由人民币3亿元增至6亿元。增资完成后，公司仍持有珠海龙图100%股权，其仍为公司的全资子公 司。 ...

Core Viewpoint - The company, Zhongtung High-tech (000657.SZ), has approved a capital increase of 127.45 million yuan for its subsidiary, Nanchang Cemented Carbide Co., Ltd., with a total capital increase of 150 million yuan from all shareholders. The funds will primarily be used for the intelligent transformation of product line equipment and to supplement working capital [1] Group 1 - The board of Zhongtung High-tech has agreed to a capital increase for its subsidiary [1] - The total amount of the capital increase is 150 million yuan, with 127.45 million yuan allocated specifically for Nanchang Cemented Carbide [1] - The purpose of the capital increase is to enhance the intelligent transformation of product line equipment and to provide additional working capital [1]